Novel enfortumab vedotin induces responses in advanced urothelial cancersJune 3, 2019Genitourinary Cancer
Laparoscopic surgery survival outcomes on par with open approach in colorectal liver metastasesJune 3, 2019GastroenterologyGastrointestinal Cancer
Pembrolizumab missed statistical cutoffs in hepatocellular carcinoma studyJune 3, 2019GastroenterologyGastrointestinal Cancer
Adjuvant CAPOX: Three months may be as good as 6 in high-risk stage II colon cancerJune 3, 2019GastroenterologyGastrointestinal Cancer
ENZAMET trial: Early enzalutamide delays progression, improves survival in mHSPCJune 3, 2019Genitourinary Cancer
Racial disparities in time to cancer care erased with Medicaid expansionJune 3, 2019Practice Management
Ado-trastuzumab highly efficacious for rare HER2-amplified SGCsJune 2, 2019Head & Neck/Thyroid Cancers
Maintenance olaparib extends PFS in pancreatic cancer with BRCA mutationJune 2, 2019GastroenterologyGastrointestinal Cancer
Ribociclib/ET improves OS in premenopausal women with HR+/HER2- breast cancerJune 2, 2019Breast Cancer
Pembro as good as chemo for gastric cancers with less toxicityJune 1, 2019GastroenterologyImmuno-oncologyGastrointestinal Cancer
SC-PEG comparable to pegaspargase in young ALL/LL patientsJune 1, 2019Leukemia, Myelodysplasia, Transplantation
Low intensity bridging may be best path to CAR T in adult ALLJune 1, 2019Leukemia, Myelodysplasia, TransplantationImmuno-oncologyImmunotherapy
